Understanding the link between SARS-CoV-2 and TDP-43 may be essential for explaining the exacerbated neurodegenerative changes observed in COVID-19 patients and may offer valuable insights into the pathological mechanisms of neurological symptoms associated with SARS-CoV-2. This evidence concerns the gene TARDBP and COVID-19.